智通财经APP讯，业聚医疗(06929)发布截至2025年6月30日止6个月中期业绩，该集团取得收入8355万美元，同比增加5.88%;公司拥有人应占期内利润1978.5万美元，同比增加5.08%;每股基本盈利2.4美仙。拟派发特别股息每股15港仙(约1.92美仙)。
公告称，尽管面对关税干扰，集团于美国市场仍取得强劲的同比增长，充分反映集团的优质产品在市场上有稳健需求。此外，在一些新兴市场，特别是亚太地区及欧洲、中东与非洲地区，持续的社经发展带来了向好的趋势，这些地区成为今年上半年的主要增长引擎。然而，由于日本市场的销量减少及中国市场的平均售价下跌，上述增幅被部分抵销。
净利增长主要由于汇兑净收益增加及所得税开支减少，但被利息收入减少以及销售及营销开支增加所抵销。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.